United States · FDA National Drug Code directory
Meloxicam
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 76282-152_d0aae8af-6204-4dd6-8c05-8137d46a5bb6
- Product NDC
- 76282-152
- Form
- TABLET
- Composition / generic term
- Meloxicam
- Labeler
- Exelan Pharmaceuticals Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20150414
- Source listing expiry
- 20261231
Source-listed ingredients
- MELOXICAM — 7.5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (76282-152-01) · 76282-152-01
- 500 TABLET in 1 BOTTLE (76282-152-05) · 76282-152-05
- 1000 TABLET in 1 BOTTLE (76282-152-10) · 76282-152-10
- 30 TABLET in 1 BOTTLE (76282-152-30) · 76282-152-30
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →